Associate Director, VALUE EVIDENCE
Phi denotes the golden ratio, which appears throughout science, art, architecture, and nature. To me, phi represents balance and connectedness. Creativity sparks innovation; innovation shapes strategy; strategy amplifies creativity.
As a member of the Value Evidence team, Greg focuses on preparing high-quality evidence-based analyses and communicating insights to a wide variety of stakeholders. Greg has over 4 years of global health economics and outcomes research consulting experience, including economic modelling, designing analysis plans, conducting literature reviews, and providing strategic consulting. He has supported both small and large biopharmaceutical companies across a variety of therapeutic areas, including oncology, hematology, nephrology, cardiovascular disease, women’s health, infectious disease, vaccines, and gene therapies.
Greg has authored over 20 manuscripts, posters, and presentations. He has a PhD in biomathematics with a concentration in mathematical methods from North Carolina State University.
- Globally recognized as an effective communicator of highly technical concepts to audiences with different interests and backgrounds.
- Awarded a National Science Foundation fellowship to promote innovation in mathematical modeling of biological systems.
- Mader G, Olufsen MS, Mahdi A. Modeling cerebral blood flow velocity during orthostatic stress. Annals of Biomedical Engineering. 2015;43(8):1748-1758.
- Yokley KA, Lee JT, Brown AK, Minor MC, Mader G. A simple agent-based model of malaria transmission investigating intervention methods and acquired immunity. Involve: a Journal of Mathematics. 2013;7(1):15-40.
Areas of Expertise
- Transforming real-world evidence into value messaging
- Economic modeling
- Outcomes research and evidence generation
- Product strategy
- Doctor of Philosophy in Biomathematics – North Carolina State University, Raleigh, NC
- BS in Mathematics – Elon University, Elon, NC